BioCentury
ARTICLE | Clinical News

Elafin regulatory update

January 14, 2013 8:00 AM UTC

Proteo said FDA granted Orphan Drug designation to Elafin for the treatment of pulmonary arterial hypertension (PAH). Elafin is in preclinical testing for the indication. The natural antagonist of el...